SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the […]
Cancer drug company Atreca terminated a nearly 100K SF lease in a San Carlos, California, property owned by Alexandria Real Estate, according to a press release and a filing with the Securities and Exchange Commission […]
WHITE CITY, Ore.–(BUSINESS WIRE)–To meet the increasing demands and projected future growth for its industry-leading MycoApply® arbuscular mycorrhizal fungi (AMF) products, Valent BioSciences LLC has announced the construction of a new manufacturing facility in White […]
Further Demonstrating Continuous Growth, Company Named to Inc. 5000 for Fourth Consecutive Year SANTA BARBARA, Calif., Sept. 21, 2023 /PRNewswire/ — Artera (formerly WELL Health), a SaaS digital health leader in patient communications, has recently […]
LA JOLLA—Immunotherapy, which uses the body’s own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it. Thus, cancer researchers are seeking new ways to optimize immunotherapy […]
This week, the Coalition of Kaiser Permanente Unions is negotiating a new national contract with the health care giant. More than 75,000 Kaiser Permanente health care workers across the country have voted to authorize a […]
In recognition of the donation, Houston Methodist created the John M. O’Quinn Foundation Neurodegenerative Disorders Laboratory. Click here to view original post Click here to view Texas Region Biotech Networks Trending News
Prize dubbed ‘America’s Nobel’ recognizes wide use of optical coherence tomography to manage eye disease, prevent blindness PORTLAND, Ore., Sept. 21, 2023 /PRNewswire/ — The United States’ most distinguished biomedical research award is being given […]
UC San Diego engineers have devised a new solution to control a major agricultural menace, root-damaging nematodes. Using plant viruses, they created nanoparticles that can deliver pesticides to previously unreachable soil depths. This could potentially […]
The biotech licensing whizzes at Aditum Bio, the VC firm from ex-Novartis CEO Joe Jimenez and Mark Fishman, have created their 10th company by nabbing the rights to a preclinical autoimmune drug. The new startup, […]
© 2023 Biotech Networks, LLC
